Reduced expression of FILIP1L, a novel WNT pathway inhibitor, is associated with poor survival, progression and chemoresistance in ovarian cancer

Mijung Kwon, Jae Hoon Kim, Yevangelina Rybak, Alex Luna, Chel Hun Choi, Joon Yong Chung, Stephen M. Hewitt, Asha Adem, Elizabeth Tubridy, Juan Lin, Steven K. Libutti

Research output: Contribution to journalArticlepeer-review

4 Citations (Scopus)

Fingerprint Dive into the research topics of 'Reduced expression of FILIP1L, a novel WNT pathway inhibitor, is associated with poor survival, progression and chemoresistance in ovarian cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences